監管
Pfizer agrees to $44 million Chantix class-action settlement
Pfizer agreed to a US$44 million class action settlement related to its smoking cessation drug Chantix, addressing claims about product safety disclosures.
文章預覽
Pfizer (PFE) Agreed To A $44 Million Chantix Settlement Bailey Pemberton Wed, August 12, 2026 at 3:39 PM GMT+10 2 min read PFE Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Pfizer (NYSE:PFE) agreed to a US$44 million class action settlement related to its smoking cessation drug Chantix, addressing claims tied to product safety disclosures. The company reported positive topline Phase 3 results for LITFULO in adults and adolescents with nonsegmental vitiligo, highlighting progress in its immunology pipeline. Both developme…